BIOMEDICINE. MEDICINAL PRODUCTS AND PUBLIC HEALTH. THE CEFI FOUNDATION’S PHARMACEUTICAL LAW COURSE

We are currently preparing the contents for the next Pharmaceutical Law Course, which will take place at the end of September.

We will review the most relevant aspects and current issues related to medicinal products, analysing the research process, the need for a stable framework for innovation, patient access to innovation, and advanced therapies.

We will also be looking at protection by means of intellectual property, current events in this area and the new reality with the unitary patent.

We will also address the Spanish regulatory landscape and the reform of EU pharmaceutical legislation.

Economic issues, financing and pricing will also be discussed, as well as existing challenges and current events in this area, including evaluations, non-financed medicines, and orphan drugs.

We will conduct an in-depth analysis of the current public procurement system for innovative medicines and of pricing transparency vs. confidentiality, adopting an administrative and jurisdictional perspective. We will also focus on advance purchase agreements and joint purchasing agreements.

In addition, we will discuss other aspects that are no longer so novel, since they are now a reality, such as telemedicine and new business models, including dispensing/delivery, innovative purchasing, digital therapeutic solutions, and apps in health and medical devices.

We will dedicate a round table to the topics of medicinal product information and promotion, analysing the current situation and challenges in this area.

Compliance and ESG will form another of the areas, with analysis of the role of the General Counsel in ESG and specifically the approach to ESG within the pharmaceutical industry.

We will close the course by studying the latest developments in competition law, the most relevant and topical aspects of clinical research and the proposed European Health Care Data regulation.

We hope it will be of interest to you and that we can count on your attendance. We will inform you of the details in the coming weeks.

This post is also available in: Spanish